SCHEMBL21167697

SCHEMBL21167697

CC(=O)Nc1ccc(-c2ccc(N)c(NCc3c[nH]c4ncccc34)n2)cn1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.44
CYP3A4 P08684 4/20 0.41
MAP4K1 Q92918 2/20 0.41
SYK P43405 3/20 0.39
TDO2 P48775 1/20 0.39
CYP2C19 P33261 1/20 0.38
PTK2 Q05397 1/20 0.38
CSF1R P07333 1/20 0.37
KIT P10721 1/20 0.37
GPR84 Q9NQS5 1/20 0.37
HDAC2 Q92769 3/20 0.37
ABL1 P00519 1/20 0.36
CAMKK2 Q96RR4 1/20 0.36
NR3C1 P04150 1/20 0.36
PARP1 P09874 1/20 0.35
DHODH Q02127 1/20 0.35
HDAC1 Q13547 2/20 0.35
PDPK1 O15530 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22475864 0.90 GPR84 (0.43) MTNR1ACYP3A4MAP4K1SYKCYP2C19
SCHEMBL21167698 0.82 MTNR1A (0.42) MTNR1ACYP3A4MAP4K1SYKTDO2
SCHEMBL21167798 0.76 FGFR1 (0.54) CYP3A4SYKCYP2C19KIT
SCHEMBL12487535 0.75 MET (0.48) MTNR1ASYKTDO2GPR84
SCHEMBL16882543 0.75 MTNR1A (0.42) MTNR1ACYP3A4SYKTDO2GPR84
SCHEMBL22475696 0.73 MET (0.44) CYP3A4SYKCYP2C19GPR84
SCHEMBL22475837 0.71 MAP4K3 (0.49) PDPK1
SCHEMBL21167387 0.67 SYK (0.48) SYK
SCHEMBL21167358 0.67 GPR84 (0.37) CYP3A4CYP2C19GPR84PDPK1
SCHEMBL2197248 0.67 GPR84 (0.50) MTNR1ACYP3A4CYP2C19CSF1RKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed